SCHEMBL1899893

SCHEMBL1899893

CC(=O)Nc1ccccc1N1CCC(Oc2ncnc(Oc3ccc(S(C)(=O)=O)cc3F)c2C)CC1

nearest known ligand 0.63

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 12/20 0.63
CYP2C9 P11712 1/20 0.63
GPR6 P46095 8/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27769032 0.87 GPR119 (0.65) GPR119CYP2C9GPR6
SCHEMBL5046636 0.82 GPR119 (0.59) GPR119CYP2C9GPR6
SCHEMBL5188918 0.81 GPR119 (0.64) GPR119CYP2C9GPR6
SCHEMBL2786447 0.81 GPR119 (0.79) GPR119CYP2C9
SCHEMBL391238 0.80 GPR119 (0.63) GPR119CYP2C9
SCHEMBL388992 0.79 GPR119 (0.74) GPR119CYP2C9
SCHEMBL388993 0.79 GPR119 (0.74) GPR119CYP2C9
SCHEMBL389216 0.79 GPR119 (0.74) GPR119CYP2C9
SCHEMBL6440077 0.79 GPR119 (0.71) GPR119CYP2C9
SCHEMBL2403601 0.79 GPR119 (0.68) GPR119CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2322152-A1 Method of preparing a composition comprising a GPR119 agonist Arena Pharmaceuticals, Inc. (US) 2011-05-18 EP disclosed
EP-1997484-A2 Method of identifying GLP-1 secretagogues Arena Pharmaceuticals, Inc. (US) 2008-12-03 EP disclosed